Interestingly, this study indicated that vitamin D suppresses the nuclear factor ‘kappa-light-chain-enhancer’ of the activated B-cells (NF-κB) pathway and thereby attenuates the progression of CAD. Here, NFKB1 is linked to coronary artery disorder.